{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:32:02Z","timestamp":1790890322806,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["03\/FNO-RVOs\/2024"],"award-info":[{"award-number":["03\/FNO-RVOs\/2024"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006704","name":"Ostravsk\u00e1 Univerzita v Ostrav\u011b","doi-asserted-by":"publisher","award":["SGS06\/LF\/2024"],"award-info":[{"award-number":["SGS06\/LF\/2024"]}],"id":[{"id":"10.13039\/501100006704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["LX22NPO5103"],"award-info":[{"award-number":["LX22NPO5103"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Hospital in Ostrava"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Invasive candidiasis is a serious infectious disease that affects 2\u201310% of patients in the intensive care unit. It is caused by fungi of the genus\n                    <jats:italic>Candida<\/jats:italic>\n                    , and its diagnosis relies on multiple complex laboratory methods. Blood culture remains the gold standard for yeast detection in the bloodstream but has limited clinical utility because of its low sensitivity and prolonged turnaround time. Newer diagnostic approaches, such as molecular methods for\n                    <jats:italic>Candida spp.<\/jats:italic>\n                    DNA detection, which enable faster identificationbut still entail limitations, including variability in sensitivity. Another valuable tool is the detection of (1,3)-\u03b2-D-glucan, a polysaccharide in yeast cell walls; however, this marker lacks specificity. Timely initiation of appropriate antifungal therapy is crucial because delayed treatment is associated with increased mortality. Preventive strategies, including strict hygiene protocols and antifungal stewardship programs, are vital to reducing the incidence of invasive candidiasis. Emerging research on siderophores as candidate biomarkers for fungal infections indicates promising diagnostic potential. Given the complex pathogenesis and diverse clinical manifestations of invasive candidiasis, multifaceted diagnostic and therapeutic approaches are required. A combination of novel biomarkers, rapid molecular diagnostics, and optimized treatment strategies is essential to improve patient outcomes and reduce the complications associated with this life-threatening infection.\n                  <\/jats:p>","DOI":"10.1007\/s11046-025-01035-4","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T03:21:48Z","timestamp":1765596108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic Approaches to Invasive Candidiasis: Challenges and New Perspectives"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2641-200X","authenticated-orcid":false,"given":"Hana","family":"Slep\u010danov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-9169","authenticated-orcid":false,"given":"Radim","family":"Dobi\u00e1\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1028-8609","authenticated-orcid":false,"given":"Andrea Beatriz Serme\u00f1o","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8880-8925","authenticated-orcid":false,"given":"Marcela","family":"K\u00e1\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5361-8125","authenticated-orcid":false,"given":"Petr","family":"Hamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"issue":"15","key":"1035_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","volume":"373","author":"BJ Kullberg","year":"2015","unstructured":"Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445\u201356.","journal-title":"N Engl J Med"},{"key":"1035_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.26","volume":"4","author":"PG Pappas","year":"2018","unstructured":"Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers. 2018;4:18026.","journal-title":"Nat Rev Dis Primers"},{"issue":"Suppl 2","key":"1035_CR3","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","volume":"72","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Azoulay E, Kullberg BJ, et al. EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group. Clin Infect Dis. 2021;72(Suppl 2):S121-s127.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1035_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(22)00872-6","volume":"23","author":"M Hoenigl","year":"2023","unstructured":"Hoenigl M, Salmanton-Garc\u00eda J, Egger M, et al. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study. Lancet Infect Dis. 2023;23(6):751\u201361.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1035_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0040-1701215","volume":"41","author":"MF Gonzalez-Lara","year":"2020","unstructured":"Gonzalez-Lara MF, Ostrosky-Zeichner L. Invasive candidiasis. Semin Respir Crit Care Med. 2020;41(1):3\u201312.","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"1035_CR6","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024;24(7):e428\u201338.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"1035_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","volume":"45","author":"I Martin-Loeches","year":"2019","unstructured":"Martin-Loeches I, Antonelli M, Cuenca-Estrella M, et al. ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45(6):789\u2013805.","journal-title":"Intensive Care Med"},{"issue":"12","key":"1035_CR8","first-page":"3488","volume":"73","author":"R Rautemaa-Richardson","year":"2018","unstructured":"Rautemaa-Richardson R, Rautemaa V, Al-Wathiqi F, et al. Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital. J Antimicrob Chemother. 2018;73(12):3488\u201395.","journal-title":"J Antimicrob Chemother"},{"key":"1035_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2147\/CLEP.S459600","volume":"16","author":"D Bays","year":"2024","unstructured":"Bays D, Jenkins E, Lyman M, et al. Epidemiology of Invasive Candidiasis. Clin Epidemiol. 2024;16:549\u201366.","journal-title":"Clin Epidemiol"},{"issue":"9","key":"1035_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00134-014-3408-3","volume":"40","author":"O Lortholary","year":"2014","unstructured":"Lortholary O, Renaudat C, Sitbon K, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002\u20132010). Intensive Care Med. 2014;40(9):1303\u201312.","journal-title":"Intensive Care Med"},{"issue":"4","key":"1035_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1055\/s-0039-1696663","volume":"40","author":"J Chastre","year":"2019","unstructured":"Chastre J, Luyt CE, Wolff M. Serious infections in the ICU: evolving concepts in management and prevention. Semin Respir Crit Care Med. 2019;40(4):417\u20138.","journal-title":"Semin Respir Crit Care Med"},{"key":"1035_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01909-17","author":"CJ Clancy","year":"2018","unstructured":"Clancy CJ, Nguyen MH. Diagnosing invasive candidiasis. J Clin Microbiol. 2018. https:\/\/doi.org\/10.1128\/JCM.01909-17.","journal-title":"J Clin Microbiol"},{"key":"1035_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jof6030101","author":"I Camp","year":"2020","unstructured":"Camp I, Spettel K, Willinger B. Molecular methods for the diagnosis of invasive candidiasis. J Fungi (Basel). 2020. https:\/\/doi.org\/10.3390\/jof6030101.","journal-title":"J Fungi (Basel)"},{"issue":"3","key":"1035_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s15010-020-01395-7","volume":"48","author":"I Camp","year":"2020","unstructured":"Camp I, Manhart G, Schabereiter-Gurtner C, Spettel K, Selitsch B, Willinger B. Clinical evaluation of an in-house panfungal real-time PCR assay for the detection of fungal pathogens. Infection. 2020;48(3):345\u201355.","journal-title":"Infection"},{"issue":"5","key":"1035_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/mmy\/myz101","volume":"58","author":"C Zurl","year":"2020","unstructured":"Zurl C, Prattes J, Zollner-Schwetz I, et al. T2Candida magnetic resonance in patients with invasive candidiasis: strengths and limitations. Med Mycol. 2020;58(5):632\u20138.","journal-title":"Med Mycol"},{"issue":"2","key":"1035_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlad035","volume":"5","author":"R de Patroc\u00ednio Jesus","year":"2023","unstructured":"de Patroc\u00ednio Jesus R, Houston H, Schutte AHJ, et al. T2Candida assay: diagnostic performance and impact on antifungal prescribing. JAC Antimicrob Resist. 2023;5(2):dlad035.","journal-title":"JAC Antimicrob Resist"},{"key":"1035_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40506-020-00209-6","volume":"12","author":"CJ Clancy","year":"2020","unstructured":"Clancy CJ, Nguyen MH. What is new in Candida infections? T2Candida, antifungal stewardship, and Candida auris. Curr Treat Options Infect Dis. 2020;12:1\u201312.","journal-title":"Curr Treat Options Infect Dis"},{"issue":"5","key":"1035_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz136","volume":"6","author":"MC Arendrup","year":"2019","unstructured":"Arendrup MC, Andersen JS, Holten MK, et al. Diagnostic performance of T2Candida among ICU patients with risk factors for invasive candidiasis. Open Forum Infect Dis. 2019;6(5):ofz136.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"1035_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/cid\/ciab928","volume":"75","author":"BT Fisher","year":"2022","unstructured":"Fisher BT, Boge CLK, Xiao R, et al. Multicenter prospective study of biomarkers for diagnosis of invasive candidiasis in children and adolescents. Clin Infect Dis. 2022;75(2):248\u201359.","journal-title":"Clin Infect Dis"},{"key":"1035_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jof9080813","author":"CP Eades","year":"2023","unstructured":"Eades CP, Bakri A, Lau JCY, et al. Comparison of \u03b2-1-3-D-glucan and Candida mannan biomarker assays with serological tests for the diagnosis of candidemia. J Fungi (Basel). 2023. https:\/\/doi.org\/10.3390\/jof9080813.","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"1035_CR21","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","volume":"50","author":"M Bassetti","year":"2024","unstructured":"Bassetti M, Giacobbe DR, Agvald-Ohman C, et al. Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM. Intensive Care Med. 2024;50(4):502\u201315.","journal-title":"Intensive Care Med"},{"issue":"3","key":"1035_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cmi.2019.09.010","volume":"26","author":"JF Cohen","year":"2020","unstructured":"Cohen JF, Ouziel A, Matczak S, et al. Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(3):291\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"1035_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","volume":"71","author":"JP Donnelly","year":"2020","unstructured":"Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367\u201376.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1035_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jof7010014","volume":"29","author":"MA Finkelman","year":"2020","unstructured":"Finkelman MA. Specificity influences in (1\u21923)-\u0392-D-glucan-supported diagnosis of invasive fungal disease. J Fungi. 2020;29(7):14.","journal-title":"J Fungi"},{"issue":"3","key":"1035_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","volume":"34","author":"C Le\u00f3n","year":"2006","unstructured":"Le\u00f3n C, Ruiz-Santana S, Saavedra P, et al. A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med. 2006;34(3):730\u20137.","journal-title":"Crit Care Med"},{"issue":"1","key":"1035_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13054-019-2525-3","volume":"23","author":"ME Laine","year":"2019","unstructured":"Laine ME, Flannery AH, Moody B, Thompson Bastin ML. Need for expanded Candida Score for empiric antifungal use in medically critically ill patients? Crit Care. 2019;23(1):242.","journal-title":"Crit Care"},{"issue":"9","key":"1035_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/14787210.2017.1370373","volume":"15","author":"W Posch","year":"2017","unstructured":"Posch W, Heimd\u00f6rfer D, Wilflingseder D, Lass-Fl\u00f6rl C. Invasive candidiasis: future directions in non-culture based diagnosis. Expert Rev Anti-Infect Ther. 2017;15(9):829\u201338.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"6","key":"1035_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1517\/13543780902911440","volume":"18","author":"MJ Rueping","year":"2009","unstructured":"Rueping MJ, Vehreschild JJ, Cornely OA. Invasive candidiasis and candidemia: from current opinions to future perspectives. Expert Opin Investig Drugs. 2009;18(6):735\u201348.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"1035_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00578290","volume":"120","author":"MA Pfaller","year":"1992","unstructured":"Pfaller MA. Laboratory aids in the diagnosis of invasive candidiasis. Mycopathologia. 1992;120(2):65\u201372.","journal-title":"Mycopathologia"},{"issue":"16","key":"1035_CR30","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1073\/pnas.1400137111","volume":"111","author":"JE Gleason","year":"2014","unstructured":"Gleason JE, Galaleldeen A, Peterson RL, et al. Candida albicans SOD5 represents the prototype of an unprecedented class of Cu-only superoxide dismutases required for pathogen defense. Proc Natl Acad Sci U S A. 2014;111(16):5866\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 11","key":"1035_CR31","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1099\/00221287-148-11-3705","volume":"148","author":"CS Hwang","year":"2002","unstructured":"Hwang CS, Rhie GE, Oh JH, Huh WK, Yim HS, Kang SO. Copper- and zinc-containing superoxide dismutase (Cu\/ZnSOD) is required for the protection of Candida albicans against oxidative stresses and the expression of its full virulence. Microbiology (Reading). 2002;148(Pt 11):3705\u201313.","journal-title":"Microbiology (Reading)"},{"issue":"31","key":"1035_CR32","doi-asserted-by":"publisher","first-page":"18967","DOI":"10.1074\/jbc.R115.644328","volume":"290","author":"EI Koh","year":"2015","unstructured":"Koh EI, Henderson JP. Microbial copper-binding siderophores at the host-pathogen interface. J Biol Chem. 2015;290(31):18967\u201374.","journal-title":"J Biol Chem"},{"key":"1035_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/jof6020073","author":"M Petrik","year":"2020","unstructured":"Petrik M, Pfister J, Misslinger M, Decristoforo C, Haas H. Siderophore-based molecular imaging of fungal and bacterial infections-current status and future perspectives. J Fungi (Basel). 2020. https:\/\/doi.org\/10.3390\/jof6020073.","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"1035_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.04068-22","volume":"11","author":"D Lupt\u00e1kov\u00e1","year":"2023","unstructured":"Lupt\u00e1kov\u00e1 D, Patil RH, Dobi\u00e1\u0161 R, et al. Siderophore-based noninvasive differentiation of Aspergillus fumigatus colonization and invasion in pulmonary aspergillosis. Microbiol Spectr. 2023;11(2):e0406822.","journal-title":"Microbiol Spectr"},{"issue":"4","key":"1035_CR35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/mas.21755","volume":"42","author":"RH Patil","year":"2023","unstructured":"Patil RH, Lupt\u00e1kov\u00e1 D, Havl\u00ed\u010dek V. Infection metallomics for critical care in the post-COVID era. Mass Spectrom Rev. 2023;42(4):1221\u201343.","journal-title":"Mass Spectrom Rev"},{"key":"1035_CR36","unstructured":"Scheer C. Reported time to blood culture results in hospitals with 24\/7 microbiological service compared to hospitals with limited microbiological service: results from an international survey in 870 hospitals. ECCMID, online. 2023."},{"key":"1035_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-05872-8","volume":"21","author":"CL Ling","year":"2021","unstructured":"Ling CL, Roberts T, Soeng S, et al. Impact of delays to incubation and storage temperature on blood culture results: a multi-centre study. BMC Infect Dis. 2021;21:1\u20138.","journal-title":"BMC Infect Dis"},{"key":"1035_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13756-017-0173-4","volume":"6","author":"R K\u00f6ck","year":"2017","unstructured":"K\u00f6ck R, W\u00fcllenweber J, Horn D, Lanckohr C, Becker K, Idelevich EA. Implementation of short incubation MALDI-TOF MS identification from positive blood cultures in routine diagnostics and effects on empiric antimicrobial therapy. Antimicrob Resist Infect Control. 2017;6:12.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"1035_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0225999","volume":"14","author":"J Schwarzenbacher","year":"2019","unstructured":"Schwarzenbacher J, Kuhn SO, Vollmer M, et al. On-site blood culture incubation shortens the time to knowledge of positivity and microbiological results in septic patients. PLoS ONE. 2019;14(12):e0225999.","journal-title":"PLoS ONE"},{"issue":"1","key":"1035_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eimc.2021.08.003","volume":"40","author":"G Bou","year":"2022","unstructured":"Bou G, Calbo E, Crespo M, et al. Justification for 24\/7 clinical microbiology services. Enferm Infecc Microbiol Clin. 2022;40(1):1\u20134.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"5","key":"1035_CR41","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/myc.12746","volume":"61","author":"SC Mellinghoff","year":"2018","unstructured":"Mellinghoff SC, Hoenigl M, Koehler P, et al. EQUAL Candida score: an ECMM score derived from current guidelines to measure QUAlity of clinical candidaemia management. Mycoses. 2018;61(5):326\u201330.","journal-title":"Mycoses"},{"issue":"Suppl 7","key":"1035_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1469-0691.12039","volume":"18","author":"OA Cornely","year":"2012","unstructured":"Cornely OA, Bassetti M, Calandra T, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect. 2012;18(Suppl 7):19\u201337.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1035_CR43","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;62(4):e1-50.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"1035_CR44","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.cmi.2020.01.029","volume":"26","author":"HY Huang","year":"2020","unstructured":"Huang HY, Lu PL, Wang YL, Chen TC, Chang K, Lin SY. Usefulness of EQUAL Candida score for predicting outcomes in patients with candidaemia: a retrospective cohort study. Clin Microbiol Infect. 2020;26(11):1501\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"1035_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jof8030238","author":"A El Zakhem","year":"2022","unstructured":"El Zakhem A, El Eid R, Istambouli R, Tamim H, Kanj SS. The utility of EQUAL Candida score in predicting mortality in patients with candidemia. J Fungi. 2022. https:\/\/doi.org\/10.3390\/jof8030238.","journal-title":"J Fungi"},{"issue":"6","key":"1035_CR46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.cmi.2024.02.024","volume":"30","author":"I Camp","year":"2024","unstructured":"Camp I, F\u00fcszl A, Selitsch B, et al. Is the T2MR Candida panel a suitable alternative to the SeptiFast for the rapid diagnosis of candidemia in routine clinical practice? Clin Microbiol Infect. 2024;30(6):816\u201321.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1035_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa075","volume":"7","author":"F Lamoth","year":"2020","unstructured":"Lamoth F, Clancy CJ, Tissot F, et al. Performance of the T2Candida panel for the diagnosis of intra-abdominal candidiasis. Open Forum Infect Dis. 2020;7(3):ofaa075.","journal-title":"Open Forum Infect Dis"},{"issue":"suppl_4","key":"1035_CR48","doi-asserted-by":"publisher","first-page":"iv6","DOI":"10.1093\/jac\/dky047","volume":"73","author":"P Mu\u00f1oz","year":"2018","unstructured":"Mu\u00f1oz P, Vena A, Machado M, et al. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study. J Antimicrob Chemother. 2018;73(suppl_4):iv6\u201312.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"1035_CR49","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00292-22","volume":"60","author":"B Lucignano","year":"2022","unstructured":"Lucignano B, Cento V, Agosta M, et al. Effective rapid diagnosis of bacterial and fungal bloodstream infections by T2 magnetic resonance technology in the pediatric population. J Clin Microbiol. 2022;60(10):e0029222.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1035_CR50","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1093\/jac\/dky247","volume":"73","author":"M Giannella","year":"2018","unstructured":"Giannella M, Paolucci M, Roncarati G, et al. Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study. J Antimicrob Chemother. 2018;73(10):2856\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"1035_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/jof7121044","author":"J Helweg-Larsen","year":"2021","unstructured":"Helweg-Larsen J, Steensen M, M\u00f8ller Pedersen F, et al. Intensive care antifungal stewardship programme based on T2Candida PCR and Candida mannan antigen: a prospective study. J Fungi. 2021. https:\/\/doi.org\/10.3390\/jof7121044.","journal-title":"J Fungi"},{"key":"1035_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/jof8010086","author":"A Krifors","year":"2022","unstructured":"Krifors A, Ullberg M, Castegren M, et al. T2Candida assay in the diagnosis of intraabdominal candidiasis: a prospective multicenter study. J Fungi (Basel). 2022. https:\/\/doi.org\/10.3390\/jof8010086.","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"1035_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2023.116118","volume":"108","author":"S Yazdanpanah","year":"2024","unstructured":"Yazdanpanah S, Rahbarmah M, Motamedi M, Khodadadi H. Evaluation of the performance of the Dynamiker Fungus (1-3)-\u03b2-D-Glucan and Fungitell assay for diagnosis of candidemia: need for new cut-off development and test validation. Diagn Microbiol Infect Dis. 2024;108(2):116118.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"1035_CR54","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/jclinpath-2017-204692","volume":"71","author":"C McKeating","year":"2018","unstructured":"McKeating C, White PL, Posso R, Palmer M, Johnson E, McMullan R. Diagnostic accuracy of fungal PCR and \u03b2-d-glucan for detection of candidaemia: a preliminary evaluation. J Clin Pathol. 2018;71(5):420\u20134.","journal-title":"J Clin Pathol"},{"issue":"1","key":"1035_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diagmicrobio.2018.07.007","volume":"93","author":"P Pini","year":"2019","unstructured":"Pini P, Colombari B, Marchi E, et al. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 \u2192 3)-\u03b2-D-glucan (BDG) for diagnosis of invasive candidiasis (IC). Diagn Microbiol Infect Dis. 2019;93(1):39\u201343.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"1035_CR56","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1130-1406(06)70046-8","volume":"23","author":"C Pazos","year":"2006","unstructured":"Pazos C, Moragues M-D, Quind\u00f3s G, Pont\u00f3n J, del Palacio A. Utilidad de la detecci\u00f3n de (1\u2192 3)-\u00df-D-glucano y anticuerpos anti-micelio de Candida albicans para el diagn\u00f3stico y seguimiento terap\u00e9utico de la candidiasis invasora en pacientes neutrop\u00e9nicos adultos. Rev Iberoam Micol. 2006;23(4):209\u201315.","journal-title":"Rev Iberoam Micol"},{"issue":"11","key":"1035_CR57","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1093\/jac\/dku225","volume":"69","author":"J Fort\u00fan","year":"2014","unstructured":"Fort\u00fan J, Meije Y, Buitrago MJ, et al. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. J Antimicrob Chemother. 2014;69(11):3134\u201341.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1035_CR58","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/432470","volume":"41","author":"L Ostrosky-Zeichner","year":"2005","unstructured":"Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1\u2013>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41(5):654\u20139.","journal-title":"Clin Infect Dis"},{"key":"1035_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/jof8030308","author":"R Dobi\u00e1\u0161","year":"2022","unstructured":"Dobi\u00e1\u0161 R, K\u00e1\u0148ov\u00e1 M, Petejov\u00e1 N, et al. Combined use of presepsin and (1,3)-\u03b2-D-glucan as biomarkers for diagnosing Candida sepsis and monitoring the effectiveness of treatment in critically ill patients. J Fungi. 2022. https:\/\/doi.org\/10.3390\/jof8030308.","journal-title":"J Fungi"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-01035-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-025-01035-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-025-01035-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:03:11Z","timestamp":1771059791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-025-01035-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s11046-025-01035-4","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Ethics Committee of the University Hospital Ostrava (project number: 108\/2024; ClinicalTrials.gov ID: NCT06456151).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"4"}}